VKH
TRPX

Virtu KCG Holdings’s Therapix Biosciences Ltd. TRPX Stock Holding History

Virtu KCG Holdings’s Portfolio TRPX Stock Details TRPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-10,931
Closed -$88K – 3729
2017
Q1 		$88K Buy
+10,931
New +$96.1K ﹤0.01% 2717

Other funds holding TRPX

Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Virtu KCG Holdings's TRPX Position: Q2 2017 in Review

Virtu KCG Holdings sold out of Therapix Biosciences Ltd. (TRPX) in Q2 2017, closing a stake of 10,931 shares — an estimated $88K sold.

Virtu KCG Holdings first reported a position in TRPX in Q1 2017 and held it in 1 quarter. The position peaked at $88K in Q1 2017. 7 funds tracked by Wall St. Rank hold TRPX as of Q2 2017.

  • Virtu KCG Holdings reported no remaining Therapix Biosciences Ltd. position as of Q2 2017 after selling out during the quarter.
  • Virtu KCG Holdings sold 10,931 Therapix Biosciences Ltd. shares in Q2 2017, an estimated $88K.
  • Virtu KCG Holdings first reported a position in Therapix Biosciences Ltd. in Q1 2017 and held it in 1 quarter.
  • Virtu KCG Holdings's Therapix Biosciences Ltd. position peaked at $88K in Q1 2017.
  • 7 funds tracked by Wall St. Rank held Therapix Biosciences Ltd. as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.